GCL
AONC

Glazer Capital LLC’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Glazer Capital LLC’s Portfolio AONC Stock Details AONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-125,000
Closed -$1.29M – 272
2023
Q1 		$1.29M Sell
125,000
-1,463,414
-92% -$14.9M 0.07% 184
2022
Q4 		$16M Sell
1,588,414
-1,285,232
-45% -$12.8M 0.41% 94
2022
Q3 		$28.2M Buy
2,873,646
+39,252
+1% +$386K 0.52% 50
2022
Q2 		$27.7M Buy
2,834,394
+15,488
+0.5% +$151K 0.69% 27
2022
Q1 		$27.5M Sell
2,818,906
-35,324
-1% -$343K 0.77% 22
2021
Q4 		$27.7M Buy
2,854,230
+38,645
+1% +$376K 0.68% 25
2021
Q3 		$27.3M Buy
+2,815,585
New +$27.3M 0.48% 38

Other funds holding AONC

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Glazer Capital LLC's AONC Position: Q2 2023 in Review

Glazer Capital LLC sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q2 2023, closing a stake of 125,000 shares — an estimated $1.29M sold.

Glazer Capital LLC first reported a position in AONC in Q3 2021 and held it in 7 quarters. The position peaked at $28.2M in Q3 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q2 2023.

  • Glazer Capital LLC reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Glazer Capital LLC sold 125,000 American Oncology Network, Inc. Class A Common Stock shares in Q2 2023, an estimated $1.29M.
  • Glazer Capital LLC first reported a position in American Oncology Network, Inc. Class A Common Stock in Q3 2021 and held it in 7 quarters.
  • Glazer Capital LLC's American Oncology Network, Inc. Class A Common Stock position peaked at $28.2M in Q3 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q2 2023.

Based on Glazer Capital LLC's 13F filing for Q2 2023, filed 14 Aug 2023.